Antiarrhythmic agents: drug interactions of clinical significance TC Trujillo, PE Nolan Drug Safety 23, 509-532, 2000 | 104 | 2000 |
Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19 PP Dobesh, TC Trujillo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (11 …, 2020 | 86 | 2020 |
Intravenous immunoglobulin–associated acute renal failure: case series and literature review YM Itkin, TC Trujillo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (6 …, 2005 | 74 | 2005 |
The role of prothrombin complex concentrates in reversal of target specific anticoagulants K Babilonia, T Trujillo Thrombosis Journal 12, 1-9, 2014 | 67 | 2014 |
Key articles of dietary interventions that influence cardiovascular mortality SW Finks, A Airee, SL Chow, TE Macaulay, MP Moranville, KC Rogers, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (4 …, 2012 | 62 | 2012 |
Evaluation of a heparin-calibrated antifactor Xa assay for measuring the anticoagulant effect of oral direct Xa inhibitors J Beyer, T Trujillo, S Fisher, A Ko, SE Lind, TH Kiser Clinical and Applied Thrombosis/Hemostasis 22 (5), 423-428, 2016 | 61 | 2016 |
Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples SE Lind, ME Boyle, S Fisher, J Ishimoto, TC Trujillo, TH Kiser American journal of clinical pathology 141 (5), 665-674, 2014 | 55 | 2014 |
Clinical use of rivaroxaban: pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications T Trujillo, PP Dobesh Drugs 74, 1587-1603, 2014 | 49 | 2014 |
Rewards and advancements for clinical pharmacists SD Goodwin, SL Kane‐Gill, TMH Ng, JT Melroy, MM Hess, K Tallian, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (1 …, 2010 | 39 | 2010 |
Ranolazine: a new option in the management of chronic stable angina PP Dobesh, TC Trujillo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (12 …, 2007 | 36 | 2007 |
Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants MP Miller, TC Trujillo, KE Nordenholz The American Journal of Emergency Medicine 32 (4), 375-382, 2014 | 33 | 2014 |
Evaluation of empiric versus nomogram‐based direct thrombin inhibitor management in patients with suspected heparin‐induced thrombocytopenia TH Kiser, AM Mann, TC Trujillo, KL Hassell American journal of hematology 86 (3), 267-272, 2011 | 33 | 2011 |
Key articles and guidelines for the prevention of venous thromboembolism PP Dobesh, AK Wittkowsky, Z Stacy, WE Dager, ST Haines, LM Lopez, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (4 …, 2009 | 33 | 2009 |
Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism PP Dobesh, TC Trujillo, SW Finks Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (6 …, 2013 | 30 | 2013 |
Management of venous thromboembolism: recent advances in oral anticoagulation therapy SW Finks, TC Trujillo, PP Dobesh Annals of Pharmacotherapy 50 (6), 486-501, 2016 | 29 | 2016 |
Coagulation factor Xa (recombinant), inactivated-zhzo (andexanet alfa) hemostatic outcomes and thrombotic event incidence at an academic medical center VM Stevens, T Trujillo, SW Mueller, R MacLaren, PM Reynolds, TH Kiser Clinical and Applied Thrombosis/Hemostasis 25, 1076029619896619, 2019 | 25 | 2019 |
Reversal agents for use with direct and indirect anticoagulants MA Smythe, T Trujillo, J Fanikos American Journal of Health-System Pharmacy 73 (10_Supplement_2), s27-s48, 2016 | 23 | 2016 |
Traditional management of chronic stable angina TC Trujillo, PP Dobesh Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (12 …, 2007 | 23 | 2007 |
Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization KM Babilonia, LK Golightly, JA Gutman, KL Hassell, JN Kaiser, TH Kiser, ... Clinical and Applied Thrombosis/Hemostasis 20 (8), 799-806, 2014 | 22 | 2014 |
Cardiovascular risks of cyclooxygenase inhibition ZA Stacy, PP Dobesh, TC Trujillo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (7 …, 2006 | 21 | 2006 |